---------
EFETCH RESULT(1..3): [
1. Methods Mol Biol. 2014;1140:315-23. doi: 10.1007/978-1-4939-0354-2_23.

Screening Ligands by X-ray crystallography.

Davies DR(1).

Author information: 
(1)Emerald Bio, 7869 NE Day Road W, Bainbridge Island, WA, 98110, USA,
ddavies@embios.com.

X-ray crystallography is an invaluable technique in structure-based drug
discovery, including fragment-based drug discovery, because it is the only
technique that can provide a complete three dimensional readout of the
interaction between the small molecule and its macromolecular target. X-ray
diffraction (XRD) techniques can be employed as the sole method for conducting a 
screen of a fragment library, or it can be employed as the final technique in a
screening campaign to confirm putative "hit" compounds identified by a variety of
biochemical and/or biophysical screening techniques. Both approaches require an
efficient technique to prepare dozens to hundreds of crystals for data
biochemical and/or biophysical screening techniques. Both approaches require an
efficient technique to prepare dozens to hundreds of crystals for data
collection, and a reproducible way to deliver ligands to the crystal. Here, a
general method for screening cocktails of fragments is described. In cases where 
X-ray crystallography is employed as a method to verify putative hits, the
cocktails of fragments described below would simply be replaced with single
fragment solutions.

PMID: 24590727